Autofluorescence

Speed: Around 5 minutes

View of 200° of the retina with a wide field

Considering 1 very specific layer: the RPE

What is Autofluorescence?

Autofluorescence is a technique that allows the metabolic changes that occur in the retinal pigment epithelium (RPE), an essential layer to keep photoreceptor cells in good health, to be viewed in great detail.
The information provided by this test helps the ophthalmologist to study the origin and evolution of certain retinal pathologies to make a more precise diagnosis and select the most appropriate treatment in each case.

What does it consist of?

Autofluorescence leverages the fluorescent properties of a metabolic indicator called lipofuscin, which is present in the fundus of the eye as a result of light stimulation of the cellular pigments of the retinal pigment epithelium.
Thanks to the development of diagnostic imaging technologies, the study of lipofuscin accumulation patterns can be performed in a non-invasive way for the patient, while viewing its deposits in vivo, since an increase or decrease in certain areas reflects pathological alterations.
Wide-field systems are very useful to reach even the most peripheral areas, which require a single image capture to view 200° of the retina (vs 30 – 45° of the central field).

How is it performed?

This test is performed in about 5 minutes. To do so, it is necessary to dilate the pupil with drops (mydriatic eye drops) that take effect in about 15 minutes. As a result of the increased pupil diameter, the patient experiences blurred vision and glare, although these symptoms disappear after a few hours.

In what cases is it used?

Autofluorescence is indicated for patients with retinal disorders that affect the pigment epithelium, the main ones being retinal dystrophies and AMD, in addition to drug toxicity, posterior uveitis, or some intraocular tumours, among others.
This technique is especially useful in unexplained visual acuity losses and in hereditary retinal dystrophies, such as retinitis pigmentosa or Stargardt disease. The processes involved have been shown to be related to alterations in this layer, which can help identify the specific type of dystrophy and guide genetic counselling.

Associated Pathologies

High myopia operation
Retinitis pigmentosa
Ocular tumours treatment
Uveitis treatment
AMD treatment
Stargardt disease

Associated Treatments

Scleral surgery intraocular tumour
Laser photocoagulation
Intravitreal injections
Laser in intraocular tumours
Ruthenium plaque brachytherapy
Tumour resection
Photodynamic therapy

Autofluorescence